RAS - Targeted Drug Discovery Europe is a conference dedicated to therapeutic opportunity of targeting RAS through novel target site discovery.
RAS - Targeted Drug Discovery Europe covers topics such as:
- RAS drug discovery efforts - harnessing the latest tools and technologies
- The latest understanding of the dynamics and function of RAS biology to identify mutation
- Predictability of patient-derived RAS-models, patient selection and anti-RAS combination strategies
- Drug resistance, chemistry & pharmacology hurdles of rational and direct anti-RAS therapies for robust translation into clinical development
- Momentum to reverse the undruggable nature of RAS proteins and seize the enormous therapeutic potential in anti-RAS strategies
RAS - Targeted Drug Discovery Europe brings together senior attendees from large pharma, biotech and academia.
